BAJAJ BROKING

Notification
No new Notification messages
Tankup Engineers IPO is Open!
Apply for the Tankup Engineers IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

29452

544350

AGARWALEYE

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

DR AGARWALS HEALTH CARE L performance

Today’s low

Today’s high

₹ 381.40 ₹ 393.00
₹ 386.70

52 week low

52 week high

₹ 361.10 ₹ 464.00
₹ 386.70

Open Price

₹ 387.25

Prev. Close

₹ 389.45

Volume (Shares)

82571.00

Total traded value

₹ 319.30

Upper Circuit

₹ 467.30

Lower Circuit

₹ 311.60

info

DR AGARWALS HEALTH CARE L Share Price Update

As of the latest trading session, DR AGARWALS HEALTH CARE L share price is currently at ₹ 386.5, which is down by -2.95 from its previous closing. Today, the stock has fluctuated between ₹ 381.40 and ₹ 393.00. Over the past year, DR AGARWALS HEALTH CARE L has achieved a return of 0.00 %. In the last month alone, the return has been -11.88 %. Read More...

DR AGARWALS HEALTH CARE L fundamentals


  • Market cap (Cr)

    360.57

  • P/E Ratio (TTM)

    519.67

  • Beta

    0.55

  • Book Value / share

    49.02

  • Return on equity

    1.44%

  • EPS (TTM)

    0.49

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    7.62

info icon alternate text
  • Market cap (Cr)

    360.67

  • P/E Ratio (TTM)

    519.67

  • Beta

    0.59

  • Book Value / share

    49.02

  • Return on equity

    1.44%

  • EPS (TTM)

    0.49

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    7.62

info icon alternate text

DR AGARWALS HEALTH CARE L Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 267.93
Operating Expense 265.60
Net Profit 7.62
Net Profit Margin (%) 2.84
Earnings Per Share (EPS) 0.25
EBITDA 74.47
Effective Tax Rate (%) 37.02
Particulars SEP 2024 (Values in Cr)
Revenue 255.34
Operating Expense 259.43
Net Profit -3.68
Net Profit Margin (%) -1.44
Earnings Per Share (EPS) -0.13
EBITDA 62.42
Effective Tax Rate (%) 745.61
Particulars DEC 2023 (Values in Cr)
Revenue 212.89
Operating Expense 211.02
Net Profit 9.61
Net Profit Margin (%) 4.51
Earnings Per Share (EPS) 0.92
EBITDA 68.57
Effective Tax Rate (%) 37.10
Particulars MAR 2024 (Values in Cr)
Revenue 835.06
Operating Expense 828.39
Net Profit 23.83
Net Profit Margin (%) 2.85
Earnings Per Share (EPS) 25.55
EBITDA 259.09
Effective Tax Rate (%) 46.64
Particulars MAR 2023 (Values in Cr)
Revenue 597.64
Operating Expense 591.98
Net Profit 31.59
Net Profit Margin (%) 5.28
Earnings Per Share (EPS) 39.83
EBITDA 147.78
Effective Tax Rate (%) 640.92
Particulars MAR 2022 (Values in Cr)
Revenue 361.59
Operating Expense 372.90
Net Profit -1.47
Net Profit Margin (%) -0.40
Earnings Per Share (EPS) -2.15
EBITDA 94.91
Effective Tax Rate (%) -54.73
Particulars MAR 2021 (Values in Cr)
Revenue 232.24
Operating Expense 288.08
Net Profit -54.08
Net Profit Margin (%) -23.28
Earnings Per Share (EPS) -78.83
EBITDA 35.44
Effective Tax Rate (%) -3.64
Particulars MAR 2024 (Values in Cr)
Book Value / Share 1435.71
ROE % 7.45
ROCE % 10.39
Total Debt to Total Equity 0.93
EBITDA Margin 29.02
Particulars MAR 2023 (Values in Cr)
Book Value / Share 794.29
ROE % 18.14
ROCE % 11.67
Total Debt to Total Equity 1.77
EBITDA Margin 28.33
Particulars MAR 2022 (Values in Cr)
Book Value / Share 309.59
ROE % 14.67
ROCE % 12.50
Total Debt to Total Equity 2.06
EBITDA Margin 29.22
Particulars MAR 2021 (Values in Cr)
Book Value / Share 268.57
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.80
EBITDA Margin 19.20
Particulars MAR 2020 (Values in Cr)
Book Value / Share 363.01
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.65
EBITDA Margin 25.71
Particulars MAR 2024 (Values in Cr)
Book Value / Share 1315.31
ROE % 1.44
ROCE % 6.43
Total Debt to Total Equity 0.70
EBITDA Margin 29.52
Particulars MAR 2023 (Values in Cr)
Book Value / Share 708.15
ROE % 11.95
ROCE % 8.10
Total Debt to Total Equity 1.11
EBITDA Margin 29.24
Particulars MAR 2022 (Values in Cr)
Book Value / Share 289.96
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.03
EBITDA Margin 26.69
Particulars MAR 2021 (Values in Cr)
Book Value / Share 293.27
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.66
EBITDA Margin 15.76
Particulars MAR 2020 (Values in Cr)
Book Value / Share 371.10
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.50
EBITDA Margin 22.12
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 124.86
Total Assets 2752.81
Total Liabilities 2752.81
Total Equity 1379.51
Share Outstanding 9329292
Price to Book Ratio 0.00
Return on Assets (%) 3.01
Return on Capital (%) 4.7
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 148.53
Total Assets 1825.17
Total Liabilities 1825.17
Total Equity 659.07
Share Outstanding 7926103
Price to Book Ratio 0.00
Return on Assets (%) 5.15
Return on Capital (%) 9.27
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 116.68
Total Assets 1026.13
Total Liabilities 1026.13
Total Equity 233.82
Share Outstanding 6859969
Price to Book Ratio 0.00
Return on Assets (%) 3.67
Return on Capital (%) 7.19
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 63.37
Total Assets 2186.94
Total Liabilities 2186.94
Total Equity 1227.21
Share Outstanding 9329292
Price to Book Ratio 0.00
Return on Assets (%) 1.08
Return on Capital (%) 1.53
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 97.48
Total Assets 1387.58
Total Liabilities 1387.58
Total Equity 561.56
Share Outstanding 7926103
Price to Book Ratio 0.00
Return on Assets (%) 2.27
Return on Capital (%) 3.64
Particulars MAR 2024 (Values in Cr)
Net Income 140.56
Cash from Operations 378.05
Cash from Investing -913.86
Cash from Financing 552.67
Net change in Cash -15.23
Free Cash Flow 610.36
Particulars MAR 2023 (Values in Cr)
Net Income 83.59
Cash from Operations 268.48
Cash from Investing -509.08
Cash from Financing 303.33
Net change in Cash 27.36
Free Cash Flow 426.29
Particulars MAR 2022 (Values in Cr)
Net Income 56.76
Cash from Operations 179.92
Cash from Investing -155.35
Cash from Financing 35.43
Net change in Cash 44.41
Free Cash Flow 250.51
Particulars MAR 2021 (Values in Cr)
Net Income -48.35
Cash from Operations 106.65
Cash from Investing -36.56
Cash from Financing -37.10
Net change in Cash 16.55
Free Cash Flow 233.20
Particulars MAR 2020 (Values in Cr)
Net Income -10.80
Cash from Operations 119.58
Cash from Investing -79.74
Cash from Financing -73.49
Net change in Cash -55.58
Free Cash Flow 321.09
Particulars MAR 2024 (Values in Cr)
Net Income 44.66
Cash from Operations 234.55
Cash from Investing -817.60
Cash from Financing 570.41
Net change in Cash -25.61
Free Cash Flow 368.61
Particulars MAR 2023 (Values in Cr)
Net Income -5.84
Cash from Operations 164.97
Cash from Investing -435.57
Cash from Financing 315.94
Net change in Cash 33.06
Free Cash Flow 241.43
Particulars MAR 2022 (Values in Cr)
Net Income -0.95
Cash from Operations 86.20
Cash from Investing -98.43
Cash from Financing 40.16
Net change in Cash 20.03
Free Cash Flow 164.48
Particulars MAR 2021 (Values in Cr)
Net Income -52.18
Cash from Operations 51.20
Cash from Investing -26.44
Cash from Financing -21.11
Net change in Cash -1.27
Free Cash Flow 74.42
Particulars MAR 2020 (Values in Cr)
Net Income -35.66
Cash from Operations 43.24
Cash from Investing -36.78
Cash from Financing -59.80
Net change in Cash -56.18
Free Cash Flow 175.09
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7161.00 78.59 13.74 102964.19 5690.80 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 78.38 191.17 4.92 146.90 51.01 / 98.70
SHREE PACETRONIX LTD. 70.50 14.69 1.88 25.38 61.11 / 268.50
TRANSGENE BIOTEK LTD. 3.90 0.00 2.72 29.55 3.22 / 10.84
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7161.00 85.68 12.57 102964.19 5690.80 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 33.60 0.00 -17.99 25.10 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5598.45 29.67 6.29 6124.70 3750.00 / 6400.00

DR AGARWALS HEALTH CARE L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
387.00 -0.62 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 397.60
  • 26 Days 415.20
  • 10 Days 405.10
  • 50 Days 417.00
  • 12 Days 407.50
  • 100 Days 418.00
  • 20 Days 413.40
  • 200 Days 418.00
395.85 PIVOT

First Support

389.70

First Resistance

404.30

Second Support

381.25

Second Resistance

410.45

Third Support

375.10

Third Resistance

418.90

RSI

35.68

ADX

31.57

MACD

-7.79

Williams % R

-71.33

Commodity Channel Index (CCI)

-115.87

Date

2025-04-24

Week

149288.00

Same Day

244496.00

Month

119357.00

1 Year

0.56

3 Year

0.56

Over 1 Month

-11.88%

down

Over 1 Year

0.00%

down

Over 3 Months

-3.03%

down

Over 3 Years

0.00%

down

Over 6 Months

0.00%

down

Over 5 Years

0.00%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

DR AGARWALS HEALTH CARE L shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
1.71%
Promoter Holdings
32.45%
FII
60.61%
DII
5.21%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Hyperion Investments Pte Ltd 7.3193988E7 (23.17%) Public Shareholding
Claymore Investments (mauritius) Pte Ltd 3.22963E7 (10.22%) Public Shareholding
Arvon Investments Pte Ltd 3.127547E7 (9.9%) Public Shareholding
Government Of Singapore 2.0485625E7 (6.49%) Public Shareholding
Dr. Athiya Agarwal 1.8929851E7 (5.99%) Shareholding of Promoter and Promoter Group
Dr. Anosh Agarwal 1.8458922E7 (5.84%) Shareholding of Promoter and Promoter Group
Dr. Amar Agarwal 1.5648321E7 (4.95%) Shareholding of Promoter and Promoter Group
Dr. Ashvin Agarwal 1.5044121E7 (4.76%) Shareholding of Promoter and Promoter Group
Dr. Adil Agarwal 1.4559452E7 (4.61%) Shareholding of Promoter and Promoter Group
Adil Agarwal, Anosh Agarwal, Ashvin Agarwal 1.3540361E7 (4.29%) Shareholding of Promoter and Promoter Group
Polar Capital Funds Plc - Healthcare Opportunities 7736753.0 (2.45%) Public Shareholding
Motilal Oswal Small Cap Fund 5172703.0 (1.64%) Public Shareholding
Dr. Agarwal's Eye Institute Private Limited 4342320.0 (1.37%) Shareholding of Promoter and Promoter Group
Monetary Authority Of Singapore 3202207.0 (1.01%) Public Shareholding
Farah Agarwal 743815.0 (0.24%) Shareholding of Promoter and Promoter Group
Urmila Agarwal 743785.0 (0.24%) Shareholding of Promoter and Promoter Group
Dr. Ashar Agarwal 493020.0 (0.16%) Shareholding of Promoter and Promoter Group
Centaur Healthtech Llc - Usa 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Printrack 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Maya Furniture Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Grf Bio Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Fab Infinity Consultancy (opc) Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Orbit International 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Chestnut Storeys Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Centaur Billing Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Maatrum Technologies And Legal Ventures Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Linendots Design Consultants Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Elisar Life Sciences Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Ace Associates 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Anosh Agarwal Holding On Behalf Of Dr. Ashar Agarwal Family Trust 30.0 (0.0%) Shareholding of Promoter and Promoter Group
Anosh Agarwal Holding On Behalf Of Dr. Ashvin Agarwal Family Trust 30.0 (0.0%) Shareholding of Promoter and Promoter Group
Anosh Agarwal Holding On Behalf Of Dr. Amar Agarwal Family Trust 30.0 (0.0%) Shareholding of Promoter and Promoter Group
Anosh Agarwal Holding On Behalf Of Dr. Adil Agarwal Family Trust 30.0 (0.0%) Shareholding of Promoter and Promoter Group
Anosh Agarwal Holding On Behalf Of Dr. Anosh Agarwal Family Trust 30.0 (0.0%) Shareholding of Promoter and Promoter Group
Aira Agarwal 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Aneira Agarwal 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Azai Agarwal 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Arick Agarwal 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Ananya Seth Agarwal 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Amaarah Agarwal 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Agastya Agarwal 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Ashvin Agarwal Huf 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Pankaj Sondhi 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sunitha Rana Agarwal 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Ayesha Fazilath Fiaz 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Shakira Ahmed 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Fiaz Ahmed 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Rajesh Kumar Kakkar 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Geeta Kakkar 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Aanchal Kakkar 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sahiba Sadiq 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Maqsood Ahmed 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Kouser Basheer 0.0 (0.0%) Shareholding of Promoter and Promoter Group
P G Thomas 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Neena Thomas 0.0 (0.0%) Shareholding of Promoter and Promoter Group
George Pt 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Fouzia Khan 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Muktha Seth 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Kamalesh Kumar Seth 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Tejeshwar Seth 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Kaamna Kakkar 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Rambha Seth 0.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

DR AGARWALS HEALTH CARE L corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

DR AGARWALS HEALTH CARE L Share Price

Dr Agarwal's Health Care Limited was incorporated as Dr. Agarwal's Health Care Limited' pursuant to Certificate of Incorporation dated April 19, 2010, issued by the Registrar of Companies, Tamil Nadu at Chennai and commenced operations pursuant to Certificate for Commencement of Business dated May 29, 2010, issued by the RoC.

The Company provide eye care services and products, covering cataract surgeries, refractive treatments and other surgeries; and services such as consultations, clinical investigations and diagnoses and non-surgical treatments; and sell opticals, contact lenses and accessories, and eye care related pharmaceutical products. It offer surgeries for multiple eye ailments, including cataract, corneal, retinal, and refractive, and other surgeries. It provide other treatments, including glaucoma treatments, squint treatments, and oculoplasty surgeries, among others. Some of the key surgical capabilities include intraocular lens procedures, cornea transplantation, pinhole pupilloplasty, single pass four-throw pupilloplasty and LASIK surgeries.

The Company had set up eye clinics by entering into Telangana and Karnataka markets during the year 2010. In 2012, it entered the Africa market with Dr, Amelia Buque to jointly promote eye hospitals and other health care related services in Mozambique. In addition to operations in India, the Company commenced international operations in 2012, which presently operate 15 Facilities in Africa, where it provide a range of eye care services, including treatments for cataract, glaucoma, diabetic retinopathy, retinal detachment, and dry eye, along with refractive surgeries, and paediatric and neuro ophthalmological.

Further, the Company acquired hospitals in Maharashtra in 2017. It launched the 100th eye care facility in 2021; further it strengthened the Gujarat market by acquiring the eye care business in 2022; acquired Punjab Eye Hospital in 2023; acquired an eye care business in Varanasi, Uttar Pradesh and acquired Dr Thind Eye Care Private Limited in Punjab in 2024.

The Company is planning an IPO by raising funds through Fresh Issue Equity Shares of Rs 300 Crore and by issuing upto 69,568,204 Equity Shares through Offer for Sale.

Parent organization Indian Private
NSE symbol AGARWALEYE
Founded 2010
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Dr Agarwals Health Care Ltd?

Answer Field

The share price of Dr Agarwals Health Care Ltd for NSE is ₹ 386.5 and for BSE is ₹ 386.6.

What is the Market Cap of Dr Agarwals Health Care Ltd?

Answer Field

The market cap of Dr Agarwals Health Care Ltd for NSE is ₹ 3,60.57 Cr. and for BSE is ₹ 3,60.67 Cr. as of now.

What is the 52 Week High and Low of Dr Agarwals Health Care Ltd?

Answer Field

The 52 Week High and Low of Dr Agarwals Health Care Ltd for NSE is ₹ 464.00 and ₹ 361.10 and for BSE is ₹ 463.85 and ₹ 370.10.

How to Buy Dr Agarwals Health Care Ltd share?

Answer Field

You can trade in Dr Agarwals Health Care Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Dr Agarwals Health Care Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the Current Share Price of Dr Agarwals Health Care Ltd?

Answer Field

Dr Agarwals Health Care Ltd share price is for NSE ₹ 386.5 & for BSE ₹ 386.6 as on Apr 25 2025 03:30 PM.

What is the Market Cap of Dr Agarwals Health Care Ltd Share?

Answer Field

The market cap of Dr Agarwals Health Care Ltd for NSE ₹ 3,60.57 & for BSE ₹ 3,60.67 as on Apr 25 2025 03:30 PM.

What is the P/E Ratio of Dr Agarwals Health Care Ltd Share?

Answer Field

As on Apr 25 2025 03:30 PM the price-to-earnings (PE) ratio for Dr Agarwals Health Care Ltd share is 519.67.

What is the PB ratio of Dr Agarwals Health Care Ltd Share?

Answer Field

As on Apr 25 2025 03:30 PM, the price-to-book (PB) ratio for Dr Agarwals Health Care Ltd share is 49.02.

How to Buy Dr Agarwals Health Care Ltd Share?

Answer Field

You can trade in Dr Agarwals Health Care Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Dr Agarwals Health Care Ltd Share on Bajaj Broking App?

Answer Field

To buy Dr Agarwals Health Care Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Dr Agarwals Health Care Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|